The global peptide therapeutics market is projected to grow at a significant CAGR of around 9.0% during the forecast period. Peptides are composed of short chains of amino acid monomers linked together via peptide bonds and occur naturally in the human body. Peptides are very specific in activity when compared to small molecules when used as a drug candidate. Generally having fewer side effects, peptides have become popular candidates for drug design. During the past decade, peptides have gained a wide range of applications in medicine and biotechnology, and therapeutic peptide research is also currently experiencing a renaissance for commercial reasons.
Get Free Sample link @ https://www.omrglobal.com/request-sample/peptide-therapeutics-market
The primary factor that drives the growth of the market include the incidences of cancer along with other metabolic disorders across the globe. Additionally, the rising demand for cost-efficient and effective drugs, along with the rapid R&D activities in order to manufacture novel drugs for the treatment are also likely to contribute to the growth of the market during the forecast period.
A full report of Global Peptide Therapeutics Market available @ https://www.omrglobal.com/industry-reports/peptide-therapeutics-market
Market Segmentation
Global Peptide Therapeutics Market by Route of Administration
- Oral
- Parenteral
Global Peptide Therapeutics Market by Application
- Cancer
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Amgen, Inc.
- AstraZeneca Plc
- Bachem Holding AG
- Bristol-Myers Squibb Co.
- CordenPharma InternationalGmbH
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Lonza Group AG
- Merck & Co. Inc.
- Novartis International AG
- Novo Nordisk A/S
- Pfizer, Inc.
- PolyPeptide Group
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceuticals Industries Ltd.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global peptide therapeutics market. Based on the availability of data, information related to products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/peptide-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
